Mykoderm (Miconazole Nitrate)

Miconazole nitrate, the active ingredient in Mykoderm, is an imidazole antifungal presented as a topical formulation for skin application. It is indicated for the treatment of superficial fungal infections such as athlete’s foot, ringworm, and cutaneous candidiasis, providing relief for both adult and pediatric patients across a range of dermatological conditions.

GNH USA supplies Mykoderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution and ensuring product integrity throughout the supply chain.

Mykoderm (miconazole nitrate) acts on dermatophyte and yeast infections of the skin. - Tinea corporis: clears the fungal infection on the body, reducing redness, scaling and itching. - Tinea cruris: treats fungal infection of the groin area, relieving irritation and preventing spread. - Tinea pedis: eliminates the causative fungi on the feet, improving skin condition and discomfort. - Cutaneous candidiasis: controls yeast overgrowth on the skin, promoting healing of affected areas. - Intertrigo: reduces fungal colonisation in skin folds, decreasing inflammation and moisture‑related irritation.

Topical application of Mykoderm may be associated with local skin reactions, most of which are mild and transient.

Common Side Effects: - Burning sensation: mild stinging at the application site. - Itching: temporary pruritus that usually resolves quickly. - Redness: localized erythema that fades within hours. - Dryness: skin may feel dry or flaky. - Peeling: mild skin flaking during treatment.

Serious or Rare Side Effects: - Contact dermatitis: severe allergic reaction with intense redness and swelling. - Swelling: noticeable edema of the treated area. - Blister formation: vesicles appearing at the site of use. - Widespread rash: extensive eruption beyond the application zone. - Systemic hypersensitivity: rare anaphylactic response requiring immediate medical care.

When using Mykoderm, certain precautions should be observed to ensure safety and effectiveness. - Application area: clean and dry the skin before applying the product. - Frequency: follow the prescriber’s instructions regarding how often to apply. - Age restrictions: avoid use on infants under two months unless directed by a clinician. - Allergies: discontinue use if signs of allergic reaction appear. - Concomitant skin products: do not apply other topical medications to the same area without professional advice. - Store at room temperature: keep the product below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Mykoderm may interact with other topical agents or systemic drugs that affect fungal flora.

Major Interactions (Avoid): - Systemic azole antifungals: concurrent use can increase systemic exposure and toxicity. - Corticosteroid creams: may reduce antifungal efficacy and mask infection signs. - Phototoxic agents: combined use may heighten risk of skin irritation under sunlight.

Moderate Interactions (Monitor Closely): - Other topical antimicrobials: assess for additive skin irritation. - Occlusive dressings: can enhance absorption and increase local irritation risk. - Alcohol‑based cleansers: may alter drug penetration and effectiveness. - Antifungal shampoos: simultaneous use on adjacent areas may cause cumulative irritation.